Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

US Patent 10653806 · Granted May 19, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for improved precision in detecting false-positive changepoi2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
Methods and related aspects for pathology prognosis2024
Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (2024
PSMA-based molecular-genetic reporter system2024
PSMA-binding agents and uses thereof2024
PSMA-binding agents and uses thereof2024
PSMA targeted fluorescent agents for image guided surgery2024
PSMA targeted fluorescent agents for image guided surgery2024
PSMA targeted fluorescent agents for image guided surgery2024